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Abstract
Refractive error is the most common eye disorder worldwide, and a prominent cause of blindness.
Myopia affects over 30% of Western populations, and up to 80% of Asians. The CREAM
consortium conducted genome-wide meta-analyses including 37,382 individuals from 27 studies
of European ancestry, and 8,376 from 5 Asian cohorts. We identified 16 new loci for refractive
error in subjects of European ancestry, of which 8 were shared with Asians. Combined analysis
revealed 8 additional loci. The new loci include genes with functions in neurotransmission
(GRIA4), ion channels (KCNQ5), retinoic acid metabolism (RDH5), extracellular matrix
remodeling (LAMA2, BMP2), and eye development (SIX6, PRSS56). We also confirmed
previously reported associations with GJD2 and RASGRF1. Risk score analysis using associated
SNPs showed a tenfold increased risk of myopia for subjects with the highest genetic load. Our
results, accumulated across independent multi-ethnic studies, considerably advance understanding
of mechanisms involved in refractive error and myopia.
Refractive error is the most important cause of visual impairment in the world1. Myopia, or
nearsightedness, in particular is associated with structural changes of the eye, increasing the
risk of severe complications such as macular degeneration, retinal detachment, and
glaucoma. The prevalence of myopia has been rising dramatically over the past few
decades2, and it is estimated that 2.5 billion people will be affected by myopia within a
decade3. Although several genetic loci influencing refractive error have been identified4-10,
their contribution to phenotypic variance is small, and many more loci are expected to
explain its genetic architecture.
Here the Consortium for Refractive Error and Myopia (CREAM) presents results from the
largest international genome-wide meta-analysis on refractive error with data from 32
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studies from Europe, the United States, Australia, and Asia. The meta-analysis was
performed in three stages: as a first step, we investigated genome-wide association study
(GWAS) results of 37,382 individuals from 27 populations of European ancestry
(Supplementary Note, Supplementary Table 1) using spherical equivalent as a continuous
outcome; as a second step, we aimed to test cross-ethnic transferability of the statistical
significant associations from the first stage in 8,376 individuals from 5 Asian cohorts
(Supplementary Note, Supplementary Table 1). As a third step, we performed a GWAS
meta-analysis on the combined populations (total n = 45,758). Subsequently, we examined
the influence of associated alleles on the risk of myopia in a genetic risk score analysis, and
lastly, we evaluated gene expression in ocular tissues and explored potential mechanisms by
which newly found loci may exert their effect on refractive development.
At step 1, we analyzed ~2.5 million autosomal single nucleotide polymorphisms (SNPs)
which were obtained through whole-genome imputation of genotypes to HapMap 2. The
inflation factors (γGC) of the test statistics in individual studies contributing to the meta-
analysis ranged between 0.992 and 1.050, indicating excellent within-study control of
population substructure (Supplementary Table 2). The overall lambda was 1.09, consistent
with a polygenic inheritance model for refractive error (Q-Q plot, Supplementary Figure
S1). We did not perform a lambda correction as Yang et al. have shown that in this situation
substantial genomic inflation can be expected, even in the absence of population structure
and technical artifacts11. We identified 309 SNPs that exceeding the conventional genome-
wide significance threshold of P=5.0×10−8 in the European ancestry sample. These SNPs
were clustered in 18 distinct genomic regions across 14 chromosomes (Figure 1, Table 1).
At step 2, we investigated the 18 best associated SNPs in the Asian population: ten showed
evidence of association (Table 1). The most significant association in both ancestry groups
was at a previously identified locus on chromosome 15q14 in the proximity of the GJD2
gene (SNP rs524952; Pcombined=1.44×10−15)4,12. The locus near the RASGRF1 gene was
also replicated in the meta-analysis (SNP rs4778879; Pcombined=4.25×10−11)9, the remaining
16 genome-wide significantly associated loci had not previously been reported in association
with refractive error. Those loci that were not significant in the smaller sized Asian
population mostly had a similar effect size and direction of effect as in the European
ancestry sample. At step 3, we identified 8 additional loci which exceeded genome-wide
significance in the combined analysis (Table 2). Regional and forest plots of the associated
loci are provided in Supplementary Figures 2 and 3.
Genotype distributions of the risk alleles were evaluated in Rotterdam Studies 1-3
(n=9,307). The clinical utility for the prediction of risk of myopia was evaluated by a
weighted genetic risk score analysis based on the aggregate of effects (regression
coefficients betas) of individual SNPs derived from the meta-analysis, using the middle risk
category as a reference. Risk scores ranged from a mean risk score of 1.88 (95% CI 1.86 -
1.89) in the lowest risk score category to 3.63 (95% CI 3.61-3.65) in the highest risk score
category. Having the lowest or the highest genetic risk score was associated with an odds
ratio of 0.38 (95% CI 0.18-0.77), and an odds ratio of 10.97 (95% CI 3.727-31.251) of
myopia, respectively (Figure 2). The predictive value (area under receiver operating
characteristic curve, AUC) of myopia versus hyperopia was 0.67 (95% CI 0.65-0.69), a
relatively high value for genetic factors in a complex trait13,14. The genetic variants explain
3.4% of the phenotypic variation in refractive error in the Rotterdam Study.
We examined the expression of genes harboring a genetic association signal by measuring
levels of RNA in various eye tissues, and found most of these genes expressed in the eye
(Supplementary Table 3). The genes PRSS56, LOC100506035, and SHISA6 were not
available in the expression data set; all other genes were expressed in the retina.
Subsequently, we assessed the areas where our SNP hits reside for H3K27ac modification
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marks15, and HaploReg16 annotations for marks of active regulatory elements
(Supplementary Table 4, Supplementary Figure 4). We found that many hits contain these
elements, and alteration of regulatory function is therefore a suggestive mechanism.
The widely-accepted model for myopia development is that eye growth is triggered by a
visually-evoked signaling cascade, which originates from the sensory retina, traverses the
retinal pigment epithelium and choroid, and terminates in the sclera, where active
extracellular matrix (ECM) remodeling results in a relative elongation of the eye17. Many of
the genes in or near the identified loci can be linked to biological processes that drive this
cascade. Neurotransmission in the retina is a necessary mechanism for eye growth
regulation; the most significantly associated gene GJD2 plays a role herein. This gene forms
a gap junction between neuronal cells in the retina, enabling intracellular exchange of small
molecules and ions. The other previously-reported gene RASGRF1 is a nuclear exchange
factor that promotes GDP/GTP exchange on Ras-family GTPases, and is involved in
synaptic transmission of photoreceptor responses18,19. Both GJD2 and RASGRF1 knockout
mice show retinal photoreception defects18,20. One of the newly identified genes, GRIA4
(SNP rs11601239; Pcombined=5.92×10−9) also has a potential function in this pathway. This
gene is a glutamate-gated ion channel that mediates fast synaptic excitatory
neurotransmission21, is present in various retinal cells22, has been shown to be critical for
light signaling in the retina23 and emmetropization24. Another gene involved in synaptic
transmission is A2BP1 (also known as RBFOX1; SNP rs17648524; Pcombined=5.64×10−10,
an RNA-binding splicing regulator which modulates membrane excitability25.
We identified for the first time a number of genes involved in ion transport, channel activity
and maintenance of membrane potential. KCNQ5, a potassium channel regulator (SNP
rs7744813; Pcombined=4.18×10−9), participates in the transport of K+ from the retina to the
choroid, and may contribute to voltage-gated K+ channels in photoreceptors and retinal
neurons associated with myopia26,27. CD55 (SNP rs1652333; Pcombined=3.05×10−12) is
known to elevate cytosolic calcium ion concentration. Other ion channel genes include
CACNA1D, a voltage-sensitive calcium channel regulator; KCNJ2, a regulator of potassium
ion transport; CHRNG, a nicotinic cholinergic receptor; and MYO1D, a putative binder of
calmodulin, which mediates Ca+ sensitivity to KCNQ5 ion channels.
Retinoic acid is synthesized in the retina and highly expressed in the choroid and has been
implicated in eye growth in experimental myopia models28-30. Retinol dehydrogenase 5
(RDH5), a novel refractive error susceptibility gene (SNP rs3138144;
Pcombined=4.44×10−12), is involved in the recycling of 11-cis-retinal in the visual cycle31.
Mutations in RDH5 cause congenital stationary night blindness (OMIM# 136880), a disease
associated with myopia. Other genes involved in retinoic acid metabolism are RORB (RAR-
related orphan receptor), and CYP26A1, genes that were significant in the European
ancestry studies. Notably, retinoic acid contributes to ECM remodeling by regulating cell
differentiation.
ECM remodeling of the sclera is the pathological hallmark in myopia development. LAMA2
(laminin α2, SNP rs12205363; Pcombined=1.79×10−12) is the most prominent gene in this
respect. LAMA2 forms a subunit of the heterotrimer laminins which are essential
components of basement membranes, stabilizing cellular structures and facilitating cell
migration32. The two bone morphogenic genes (BMP2, SNP rs235770;
Pcombined=1.57×10−8; BMP3) can also be placed within the ECM architecture. They are
members of the transforming growth factor-β (TGFβ) super-family, regulate growth and
differentiation of mesenchymal cells, and may orchestrate the organization of other
connective tissues than bone such as sclera. Remarkably, BMP2 shows bidirectional
expression in retinal pigment epithelium in myopia animal models33.
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Genes involved in eye development appeared as a separate entity among the gene functions.
SIX6 (SNP rs1254319; Pcombined=1.00×10−8 has been linked to anophthalmia and
glaucoma34,35, PRSS56 (protease serine 56, SNP rs1656404; Pcombined=7.86×10−11) to
microphthalmia36-38, CHD7 to CHARGE syndrome, a congenital condition with severe eye
structural defects, and ZIC2 to brain development including visual perception. For the
remaining novel gene associations, a mechanism in the pathogenesis of myopia is not
immediately clear. Results from Ingenuity and the Protein Link Evaluator39 (Supplementary
Figure 5) visualize the subcellular location of all associated genes, and illustrates their
interrelationships. Direct connections between genes were surprisingly infrequent,
suggesting molecular disease heterogeneity or functional redundancy in the pathobiological
events involved in development of refractive error and myopia.
In summary, we identified 24 new chromosomal loci associated with refractive error through
a large-scale meta-analysis of GWAS from international multi-ethnic studies. The
significant overlap in genetic loci for refractive error between subjects of European ancestry
and Asians provides evidence for shared genetic risk factors between the populations. The
tenfold increased risk of myopia for those carrying the highest number of risk alleles depicts
the clinical significance of our findings. Further elucidation of the mechanisms by which
these loci affect eye growth carries the potential to improve the visual outcome of this
common trait.
Online methods
Study design
We performed a meta-analysis on directly genotyped and imputed SNPs from individuals of
European ancestry in 27 studies, with a total of 37,382 individuals. Subsequently, we
evaluated significant SNPs in 8,376 subjects of Asian origin from 5 different studies, and
performed a meta-analysis on all studies combined.
Subjects and phenotyping
All studies participating in this meta-analysis are part of the Consortium for Refractive Error
and Myopia (CREAM). All studies had a population-based design and had a similar protocol
for phenotyping (Supplementary Table 1). Eligible participants underwent a complete
ophthalmologic examination including a non-dilated measurement of refractive error of both
eyes. Exclusion criteria were all conditions that could alter refraction, such as cataract
surgery, laser refractive procedures, retinal detachment surgery, keratoconus, or ocular or
systemic syndromes. Inclusion criteria were persons aged 25 years and over who had data on
refractive error and genotype.
The meta-analysis of step 1 was based on 27 studies of European ancestry: 1958 British
Birth Cohort, ALSPAC, ANZRAG, AREDS1a1b, AREDS1c, CROATIA-Korcula,
CROATIA-Split, CROATIA-Vis, EGCUT, FECD, TEST/BATS, FITSA, Framingham,
GHS 1, GHS 2, KORA, ORCADES, TwinsUK, WESDR, YFS, ERF, DCCT, BMES, RS1,
RS2, RS3, and OGP Talana. The second step was formed by 5 Asian studies: Beijing Eye
Study, SCES, SIMES, SINDI, and SP2.
General methods, demographics and phenotyping and genotyping methods of the study
cohorts can be found in the Supplementary Note and Supplementary Table 1. All studies
were performed with the approval of their local Medical Ethics Committee, and written
informed consent was obtained from all participants in accordance with the Declaration of
Helsinki.
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Genotyping and imputation
Particulars of genotyping in each cohort, particular platforms used to generate genotyping
and methods of imputation can be found in more detail in the Supplementary Table 5. To
produce consistent datasets and enable meta-analysis of studies across different genotyping
platforms, the cohorts performed genomic imputation on the HapMap Phase 2 available
genotypes with MACH40 or IMPUTE41, using the appropriate ancestry as templates.
Each cohort applied stringent quality control procedures prior to the imputation, including
minor allele frequency cutoffs, Hardy-Weinberg equilibrium (P > 10−7), genotypic success
rate (>95%), Mendelian inconsistencies, exclusion of individuals with more than 5% shared
ancestry (exception made for family-based cohorts in which due adjustment for family
relationship was made) and removal of all individuals whose ancestry as determined through
genetic analysis did not match the prevailing ancestry group of the own cohort. SNPs with
low imputation quality were filtered using metrics specific to the imputation method and
thresholds used in their previous GWAS analyses. Hence, imputation quality criteria varied
slightly among studies, and low-confidence imputed SNPs were omitted in the meta-analysis
for individual studies.
Statistical analysis
Spherical equivalent was calculated according to the standard formula (SE=sphere + ½
cylinder), and the mean of two eyes was used for analysis. When data from only one eye
was available, the SE of this eye was used.
Each cohort performed association analyses in which the spherical equivalent (determined as
described above) was the dependent variable and genotypes (number of alleles in each of the
HapMap2 loci) as the independent variables. Analyses in all cases also adjusted for sex and
age at the time of phenotype measurement. In family-based cohorts score-test based
association test was used to adjust for within-family relatedness (see Supplementary
Note)42,43. Study-specific lambda estimates are shown in Supplementary Table 2.
All study effect estimates were corrected using genomic control and were oriented to the
positive strand of the NCBI build 36 reference sequence of the human genome, which was
the genomic build on which most available genotyping platforms were based. The
coordinates and further annotations of the SNPs were further converted into build 37, the
most recent of the available builds at the time of writing.
Meta-analyses used effect size estimations (beta regression coefficients) and standard errors
from individual cohorts’ summary statistics. Random-effects were assumed for all the meta-
analyses which were performed using GWAMA44. We tested for heterogeneous effects
between the two ancestries using METAL45 for Linux. For the purpose of these analyses, we
defined significance as equal to or better than the conventional multiple testing genome-
wide thresholds of association (P<5.0 × 10−8) for stage 1 and nominally significant
probabilities (P<0.05) for stage 2. Manhattan, regional plots and forest plots were made
using R (see URLs) and Locuszoom (see URLs)46.
For the Rotterdam Study 1-3, a weighted genetic risk score per individual was calculated
using the regression coefficients from the GWAS meta-analysis model for the association of
SNPs within the associated 26 loci (Table 1, Table 2; per locus only one SNP was included
in the analysis) and the individual allele dosages per genotype to evaluate the relationships
between myopia (SE ≤ − 3 D), emmetropia (−1.5 D ≤ SE ≤ 1.5 D) and hyperopia (SE ≥ +3
SD). The weighted risk scores were categorized and mean odds ratios per risk score category
were calculated for subjects with myopia versus hyperopia, using the middle risk score
category as a reference. Subsequently, the area under the receiver curve (AUC) was
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calculated for myopia versus emmetropia and myopia versus hyperopia. Lastly, the
proportion of variance of spherical equivalent explained by the identified SNPs was
calculated. For these analyses, we used SPSS version 20.0.0 (SPSS Inc.).
Gene expression data in human eye tissue
Independently designed, collected, and reported human ocular tissue array data from two
different sources, as well as literature reviews were used to verify evidence of expression of
the candidate genes.
RPE, photoreceptors and choroid
Human gene expression data of RPE, photoreceptors and choroid were obtained essentially
as described47 and the dataset has been deposited in NCBI’s Gene Expression Omnibus48
(GEO series accession number GSE20191; see URLs). In short, postmortem eye bulbs
(retinal pigment epithelium was obtained from six donor eyes, choroid was obtained from
three donor eyes and photoreceptors were obtained from three donor eyes), provided by the
Corneabank Amsterdam, were rapidly frozen using liquid nitrogen. Donors were between 63
and 78 years old and had no known history of eye pathology. Cryosections were cut from
the macula, and histology was used to confirm a normal histological appearance. Retinal
pigment epithelium, photoreceptor and choroidal cells were isolated from macular sections
using a Laser Microdissection System (PALM). Total RNA was isolated and the mRNA
component was amplified, labeled and hybridized to a 44K microarray (Agilent
Technologies)49. At least three to six microarrays were performed per tissue. Sample
isolation, procedures and expression microarray analysis were carried out according to
MIAMI guidelines. As a measure of the level of expression, we sorted all the genes
represented on the 44K microarray by increasing their expression, and we calculated the
corresponding percentiles (Supplementary Table 3a).
Sclera, cornea and optic nerve
We assessed expression of the associated genes in sclera, cornea and optic nerve tissue in an
additional dataset (unpublished data). Adult eyes were obtained from the North Carolina Eye
Bank (Winston-Salem, North Carolina). All whole globes were immersed in RNALater
(Quiagen, Hilden, Germany) within 6.5 hours of collection, shipped overnight on ice, and
dissected on the day of arrival. The retina, choroid and scleral tissues were isolated at the
posterior pole using a circular, double embedded technique using round 7 mm and 5 mm
biopsy punches. To reduce contamination of retina to the other ocular tissues samples, the
second biopsy punch of 5 mm was used in the center of the 7 mm punch after retinal
removal. RNA samples (quality control of RNA concentration and 260/280 nm ratios using
Nanodrop®) (Invitrogen, Carlsbad, California, USA) were hybridized to whole genome
microaray Illumina® HumanHT-12 v4 Expression BeadChips (over 25,000 genes and
48,000 probes) in two batches. The first batch was hybridized to adult RPE, choroid, and
sclera RNA samples (n=6). The second batch of newer chips with additional probes was
hybridized to adult optic nerve and cornea samples (n=6). The data were exported from
Illumina® GenomeStudio and log2 transformed. Sample outliers were determined by
principle component analyses using the Hoteling’s T2 test50 (at 95% confidence interval)
and removed from further analyses. The data intensity was normalized by Quantile
normalization followed by Multichip Averaging51 to reduce chip effects. For each tissue
type, the probes with signal intensities below background levels and those with the lowest
(5%) signal intensities (detection P<0.10) were excluded. Evidence of expression in the
remaining probes was defined by detection P<0.05. Probes with detection P values < 0.10
and > 0.05 required additional tissue expression support from EyeSAGE or literature reports
(Supplementary Table 3b).
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Search for regulatory elements
We used the ‘Integrated Regulation from ENCODE’ track in the UCSC genome browser to
look at H3K27ac modificiation marks as a mark of active regulatory elements. Numbers of
H3K27ac modification marks were counted between the associated topSNP from a locus
and the nearest gene and within (the nearest) gene itself. We also used HaploReg16
annotations to look for other signs of regulatory activity at the site of the associated SNP
itself, such as enhancer histone marks, DNAse hypersensitivity sites, binding proteins and
motifs changed.
Pathway analyses
We used two different programs for pathway analsysis; Ingenuity (see URLs), version
August 2012, application build 172788, content version 14197757) and the Disease
Association Protein-Protein Link Evaluator (DAPPLE)39.
Subcellular localization assignment and functional annotation of myopia associated disease
genes as well as molecular pathway analysis was carried out using the Ingenuity knowledge
database. The candidate myopia disease genes discovered in this study were entered into the
Ingenuity knowledge database (IPA). We used the “IPA toggle subcellular layout” function
to show the subcellular location (extracellular, plasma membrane, cytoplasm, nucleus,
unknown) of the proteins corresponding to these genes, which yield a first glance which
signaling molecules and pathways are involved in myopia. Subsequently, we used the IPA
“connect” function to discover potential direct or indirect functional relationships or
molecular pathways in between these entries. This yielded surprisingly little hits, which
suggest molecular disease heterogeneity and/or functional redundancy in the pathobiological
events leading to myopia. Next, we used the IPA “overlay” function to annotate the myopia
candidate disease genes with (their involvement in) “functions and diseases”, “canonical
pathways” and a range of custom made gene lists from previous studies, including
photoreceptor, RPE, and choroidal specific transcripts (partly published52). Lastly, we used
the Disease Association Protein-Protein Link Evaluator (DAPPLE)39 to look for physical
connections between proteins encoded from disease-genes associated regions.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Manhattan plot of the GWAS meta-analysis for refractive error in the combined
analysis (n = 45,758)
The plot shows −log10-transformed P values for all SNPs; the upper horizontal line
represents the genome-wide significance threshold of P < 5.0 × 10−8; the lower line
indicates P value of 10−5. Previously reported genes are depicted in grey. The A2BP1 gene
is also known as RBFOX1.
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Figure 2. Genetic risk score for myopia
Distribution of subjects from Rotterdam Study 1-3 (n= 9,307) with myopia (SE ≤ −3 D),
emmetropia (SE ≥ −1.5 D & ≤ 1.5 D) and hyperopia (SE ≥ 3 D) as a function of genetic risk
score. This score is based on the regression coefficients and allele dosages of the associated
SNPs for all 26 loci identified in the meta-analysis. The mean OR of myopia was calculated
per risk category, using the middle risk score category (risk score 2.50; 2.75) as a reference.
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